{
    "medicine_id": "5ef18e0537db93939d7871a9112c67978a37d3af",
    "platform_id": "DB11700",
    "metadata": {
        "name": "Imcivree 10 mg 1mL Solution",
        "composition": "10 mg 1mL Setmelanotide",
        "clinical_particulars": {
            "therapeutic_indications": "Setmelanotide is indicated for chronic weight management in patients 6 years and older with obesity due to pro opiomelanocortin deficiency proprotein subtilisin kexin type 1 deficiency or leptin receptor deficiency L24474 These conditions affect the MC4R signalling pathway A224454",
            "contraindications": {
                "disease": "Data regarding overdoses of setmelanotide are not readily available L24569 In the event of an overdose patients should be treated with symptomatic and supportive care L24569",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Setmelanotide agonizes MC4R downstream of multiple potential genetic deficiencies to induce a feeling of satiety for chronic weight management L24569 It has a moderate duration of action as it is given daily L24569 Patients should be counselled regarding the risk of disturbances in sexual arousal depression and suicidal ideation and darkening of skin pigmentation L24569 Exercise caution in neonates and low birth weight infants as they may experience serious adverse effects due to benzyl alcohol L24569",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}